Pressmeddelanden från ChemoMetec

Bevaka pressreleaser

Kurs från TradingView

Start Nyheter Pressreleaser Riktkurser Insynshandel Blankning Analyser Bloggar Videos Podcasts

Notification of managers’ transactions 09 feb 10:29

Notification of managers’ transactions 04 feb 18:17

ChemoMetec enters Letter of Intent with Roche Diagnostics 04 feb 18:10

Interim report 2025/26 - Organic growth despite challenges in the North American market 07 nov 2025 13:27

Notification of managers’ transactions 07 nov 2025 13:19

Notification of managers’ transactions 06 nov 2025 17:12

Growth in revenue and operating profit 28 okt 2025 11:06

Upgrade of guidance 09 okt 2025 22:01

Procedure of the Annual General Meeting 17 sep 2025 15:43

Notice of Annual General Meeting 2025 11 sep 2025 19:16

Annual Report 2024/25 - Growing revenue and EBITDA 11 sep 2025 19:12

Guidance for the 2025/26 financial year 01 jul 2025 12:46

Preliminary revenue figures for the 2024/25 financial year 07 maj 2025 17:33

Continued growth in revenue and operating profit 10 feb 2025 16:43

Notification of managers' transactions 05 feb 2025 18:55

Interim report 2024/25 - Solid H1 performance driven by growth in both revenue and earnings 10 jan 2025 09:48

Upgrade of revenue and operating profit guidance 09 dec 2024 13:35

Major shareholder announcement – AIM International Mutual Funds 09 dec 2024 13:34

Major shareholder announcement – Invesco Ltd. 03 dec 2024 15:56

Upgrade of revenue and operating profit guidance 08 nov 2024 13:28

Notification of managers’ transactions 08 nov 2024 13:27

Notification of managers’ transactions 07 nov 2024 17:12

Growth in revenue and operating profit 22 okt 2024 17:35

Closing of acquisition of Ovizio Imaging Systems SA 16 okt 2024 16:36

Acquisition of Ovizio Imaging Systems SA 16 okt 2024 16:33

Upgrade of revenue and operating profit guidance 11 okt 2024 15:43

ChemoMetec’s potential acquisition of Ovizio Imaging Systems SA 10 okt 2024 22:35

Procedure of the Annual General Meeting 20 sep 2024 17:06

ChemoMetec makes offer to buy Ovizio Imaging Systems SA 18 sep 2024 14:45

Notice of Annual General Meeting 2024 13 sep 2024 09:36

Notification of managers’ transactions 11 sep 2024 22:29

Annual Report 2023/24 - Strengthened commercial focus after challenging year 11 sep 2024 22:27

Guidance for the 2024/25 financial year 04 jul 2024 21:03

Major shareholder announcement – BlackRock, Inc.02 jul 2024 08:56

Preliminary revenue figures for the 2023/24 financial year 24 maj 2024 20:05

Appointment of new CFO 17 maj 2024 11:10

Notification of managers’ transactions 16 maj 2024 14:55

Notification of managers’ transactions 15 maj 2024 11:45

Major shareholder announcement – BlackRock, Inc. 14 maj 2024 16:35

Notification of managers’ transactions 14 maj 2024 16:04

Notification of managers’ transactions 13 maj 2024 11:05

Notification of managers' transactions 08 maj 2024 18:20

Q3 2023/24 - First sale of the XM30 completed 12 apr 2024 14:55

Clarification of guidance for revenue and lower than expected operating profit in the 2023/24 financial year 10 apr 2024 16:50

Major shareholder announcement – BlackRock, Inc. 03 apr 2024 16:05

Major shareholder announcement – Swedbank Robur Fonder AB 18 mar 2024 12:32

Major shareholder announcement – BlackRock, Inc. 18 mar 2024 12:28

Major shareholder announcement – AIM International Mutual Funds 18 mar 2024 12:25

Major shareholder announcement – Invesco Ltd.13 mar 2024 09:30

Appointment of new CEO 13 mar 2024 09:02

Appointment of new CEO 11 mar 2024 10:30

Major shareholder announcement – BlackRock, Inc.05 mar 2024 12:01

Major shareholder announcement – AIM International Mutual Funds 05 mar 2024 12:00

Major shareholder announcement - Invesco Ltd.05 feb 2024 21:45

Interim report for the first half of 2023/24 – Correction 05 feb 2024 20:00

Interim report 2023/24 - Full-year guidance maintained despite continued challenging market conditions 20 dec 2023 14:35

Martin Glensbjerg takes up new position at ChemoMetec 07 nov 2023 20:00

Q1 2023/24 - Lower revenue in a challenging market 14 sep 2023 17:20

Notification of managers’ transactions 13 sep 2023 19:50

Annual Report 2022/23 - Continued solid earnings, but weaker growth amid challenging market conditions 13 sep 2023 19:45

Guidance for the 2023/24 financial year 11 sep 2023 13:15

Major shareholder announcement - BlackRock, Inc.24 aug 2023 15:40

Major shareholder announcement - BlackRock, Inc.17 aug 2023 10:30

Major shareholder announcement 16 maj 2023 11:32

Major Shareholder Announcement - AIM international Mutual Funds 15 maj 2023 13:20

Major shareholder announcement - Invesco Ltd.08 maj 2023 17:50

Q3 2022/23 - Solid operating result in a challenging market 17 apr 2023 10:00

Appointment of new CEO 08 feb 2023 18:57

Interim report 2022/23 - 15% revenue growth and DKK 145 million operating profit (+25%) for the first half following a challenging second quarter 14 dec 2022 15:00

Management change 08 nov 2022 08:30

Q1 2022/23 - Good start to the fiscal year with 34% revenue growth 15 sep 2022 08:30

Annual Report 2021/22 - Strong growth despite challenging conditions 29 dec 2021 15:00

ChemoMetec-aktien rykker til Large Cap 30 jun 2021 11:30

Ansættelse af ny CFO